The US Food and Drug Administration (FDA) has rejected a drug developed by Covisant that was supposed to prevent preterm birth and improve neonatal outcomes. FDA said that the scientific research and medical communities haven’t found a treatment that is effective in preventing preterm birth and improving neonatal outcomes. “Faced with that powerless feeling, is…